MEDPLUS HEALTH SERVICES Financial Statement Analysis
|
||
The Revenues of MEDPLUS HEALTH SERVICES have increased by 20.59% YoY .
The Earnings Per Share (EPS) of MEDPLUS HEALTH SERVICES has increased by 31.41 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
MEDPLUS HEALTH SERVICES Last 5 Annual Financial Results
[BOM: 543427|NSE : MEDPLUS]
Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹4,558 Cr | ₹3,779 Cr | ₹3,069 Cr | ₹2,871 Cr | ₹2,273 Cr |
Expenses | ₹4,276 Cr | ₹3,490 Cr | ₹2,840 Cr | ₹2,737 Cr | ₹2,216 Cr |
Operating Profit (Excl OI) | ₹281 Cr | ₹289 Cr | ₹229 Cr | ₹134 Cr | ₹57 Cr |
Other Income | ₹46 Cr | ₹31 Cr | ₹22 Cr | ₹17 Cr | ₹9.83 Cr |
Interest | ₹99 Cr | ₹83 Cr | ₹67 Cr | ₹47 Cr | ₹16 Cr |
Depreciation | ₹182 Cr | ₹119 Cr | ₹88 Cr | ₹75 Cr | ₹14 Cr |
Profit Before Tax | ₹47 Cr | ₹118 Cr | ₹95 Cr | ₹29 Cr | ₹37 Cr |
Profit After Tax | ₹50 Cr | ₹95 Cr | ₹63 Cr | ₹1.79 Cr | ₹21 Cr |
Consolidated Net Profit | ₹50 Cr | ₹96 Cr | ₹64 Cr | ₹1.79 Cr | ₹21 Cr |
Earnings Per Share (Rs) | ₹5.48 | ₹4.17 | ₹8.03 | ₹1,425.40 | ₹92.47 |
PAT Margin (%) | 1.15 | 1.08 | 2.47 | 2.01 | 0.06 |
ROE(%) | 4.36 | 3.50 | 9.07 | 10.51 | 0.43 |
ROCE(%) | 12.19 | 9.56 | 16.56 | 21.69 | 14.34 |
Total Debt/Equity(x) | 0.00 | 0.00 | 0.10 | 0.20 | 0.20 |
Key Financials |
||
Market Cap | : | ₹ 9,526.9 Cr |
Revenue (TTM) | : | ₹ 6,116.9 Cr |
Net Profit(TTM) | : | ₹ 132.5 Cr |
EPS (TTM) | : | ₹ 11.1 |
P/E (TTM) | : | 71.9 |
Industry Peers & Returns | 1W | 1M | 1Y |
MEDPLUS HEALTH SERVICES | -4.8% | 8.9% | 21% |
SUN PHARMACEUTICAL INDUSTRIES | -4.9% | 2.1% | 15.5% |
DIVIS LABORATORIES | -2.2% | 9.3% | 50.5% |
CIPLA | -4.2% | 4.5% | 4.5% |
TORRENT PHARMACEUTICALS | -4.4% | -4.5% | 17.2% |
DR REDDYS LABORATORIES | -1.4% | 4.2% | -8.8% |
MANKIND PHARMA | -0.1% | -1.5% | 6.6% |
ZYDUS LIFESCIENCES | -1.6% | 1.3% | -14.6% |
LUPIN | -2.4% | 3.4% | 19.9% |
MEDPLUS HEALTH SERVICES Revenues
[BOM: 543427|NSE : MEDPLUS]
Y-o-Y | 20.59 % |
5 Yr CAGR | 19.00 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹4,558 Cr | 20.59 | |
Mar2023 | ₹3,779 Cr | 23.13 | |
Mar2022 | ₹3,069 Cr | 6.92 | |
Mar2021 | ₹2,871 Cr | 26.31 | |
Mar2020 | ₹2,273 Cr | - |
MEDPLUS HEALTH SERVICES Operating Profit
[BOM: 543427|NSE : MEDPLUS]
Y-o-Y | -2.60 % |
5 Yr CAGR | 49.18 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹281 Cr | -2.60 | |
Mar2023 | ₹289 Cr | 26.03 | |
Mar2022 | ₹229 Cr | 71.47 | |
Mar2021 | ₹134 Cr | 135.34 | |
Mar2020 | ₹57 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -19.24 % |
5 Yr CAGR | 25.34 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 6.17% | -19.24 | |
Mar2023 | 7.64% | 2.28 | |
Mar2022 | 7.47% | 60.30 | |
Mar2021 | 4.66% | 86.40 | |
Mar2020 | 2.5% | - |
MEDPLUS HEALTH SERVICES Profit After Tax
[BOM: 543427|NSE : MEDPLUS]
Y-o-Y | -48.06 % |
5 Yr CAGR | 24.22 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹50 Cr | -48.06 | |
Mar2023 | ₹96 Cr | 50.02 | |
Mar2022 | ₹64 Cr | 3,459.53 | |
Mar2021 | ₹1.79 Cr | -91.42 | |
Mar2020 | ₹21 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 6.48 % |
5 Yr CAGR | 109.24 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 1.15 % | 6.48 | |
Mar2023 | 1.08 % | -56.28 | |
Mar2022 | 2.47 % | 22.89 | |
Mar2021 | 2.01 % | 3,250.00 | |
Mar2020 | 0.06 % | - |
MEDPLUS HEALTH SERVICES Earnings Per Share (EPS)
[BOM: 543427|NSE : MEDPLUS]
Y-o-Y | 31.41 % |
5 Yr CAGR | -50.66 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹5.48 | 31.41 | |
Mar2023 | ₹4.17 | -48.07 | |
Mar2022 | ₹8.03 | -99.44 | |
Mar2021 | ₹1,425 | 1,441.47 | |
Mar2020 | ₹92 | - |
MEDPLUS HEALTH SERVICES Return on Capital Employed (ROCE)
[BOM: 543427|NSE : MEDPLUS]
Y-o-Y | 27.51 % |
5 Yr CAGR | -3.98 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 12.19% | 27.51 | |
Mar2023 | 9.56% | -42.27 | |
Mar2022 | 16.56% | -23.65 | |
Mar2021 | 21.69% | 51.26 | |
Mar2020 | 14.34% | - |
MEDPLUS HEALTH SERVICES Share Price vs Sensex
Current Share Price | : | ₹795.9 |
Current MarketCap | : | ₹ 9,526.9 Cr |
Updated EOD on | : | May 09,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDPLUS HEALTH SERVICES | -4.8% |
8.9% |
21% |
SENSEX | -1.3% |
4.1% |
7.6% |
MEDPLUS HEALTH SERVICES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
BSE CONSUMER DISCRETIONARY & SERVICES | -0.5% | 2.2% | -2.1% |
BSE 400 MIDSMALLCAP INDEX | -1.3% | 0.5% | NA |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MIDSMALL HEALTHCARE | -0.6% | -1.9% | 18% |
NIFTY MICROCAP 250 | -0.9% | -2.2% | -0.7% |
NIFTY 500 EQUAL WEIGHT | -1.4% | -0.2% | NA |
NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | -1.4% | 1% | NA |
NIFTY TOTAL MARKET | -1.5% | 1.9% | 3.3% |
You may also like the below Video Courses
FAQ about MEDPLUS HEALTH SERVICES Financials
How the annual revenues of MEDPLUS HEALTH SERVICES have changed ?
The Revenues of MEDPLUS HEALTH SERVICES have increased by 20.59% YoY .
How the Earnings per Share (EPS) of MEDPLUS HEALTH SERVICES have changed?
The Earnings Per Share (EPS) of MEDPLUS HEALTH SERVICES has increased by 31.41 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs